z-logo
open-access-imgOpen Access
Iron is neurotoxic in retinal detachment and transferrin confers neuroprotection
Author(s) -
Alejandra Daruich,
Quentin Le Rouzic,
Laurent Jonet,
MarieChristine Naud,
Laura Kowalczuk,
JeanAntoine Pournaras,
Jeffrey H. Boatright,
Aurélien Thomas,
Natacha Turck,
Alexandre Moulin,
Francine BéharCohen,
Émilie Picard
Publication year - 2019
Publication title -
science advances
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.928
H-Index - 146
ISSN - 2375-2548
DOI - 10.1126/sciadv.aau9940
Subject(s) - transferrin , neuroprotection , retinal detachment , retinal , medicine , transferrin receptor , ophthalmology , pharmacology
In retinal detachment (RD), photoreceptor death and permanent vision loss are caused by neurosensory retina separating from the retinal pigment epithelium because of subretinal fluid (SRF), and successful surgical reattachment is not predictive of total visual recovery. As retinal iron overload exacerbates cell death in retinal diseases, we assessed iron as a predictive marker and therapeutic target for RD. In the vitreous and SRF from patients with RD, we measured increased iron and transferrin (TF) saturation that is correlated with poor visual recovery. In ex vivo and in vivo RD models, iron induces immediate necrosis and delayed apoptosis. We demonstrate that TF decreases both apoptosis and necroptosis induced by RD, and using RNA sequencing, pathways mediating the neuroprotective effects of TF are identified. Since toxic iron accumulates in RD, we propose TF supplementation as an adjunctive therapy to surgery for improving the visual outcomes of patients with RD.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom